Ethic Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.08M | Sell |
72,744
-5,275
| -7% | -$368K | 0.09% | 231 |
|
2025
Q1 | $5.66M | Sell |
78,019
-19,589
| -20% | -$1.42M | 0.11% | 198 |
|
2024
Q4 | $6.4M | Buy |
97,608
+6,475
| +7% | +$424K | 0.13% | 168 |
|
2024
Q3 | $6.17M | Sell |
91,133
-16,607
| -15% | -$1.13M | 0.16% | 153 |
|
2024
Q2 | $8.4M | Buy |
107,740
+16,607
| +18% | +$1.3M | 0.2% | 104 |
|
2024
Q1 | $6.17M | Buy |
91,133
+4,158
| +5% | +$282K | 0.16% | 153 |
|
2023
Q4 | $5.86M | Buy |
86,975
+8,394
| +11% | +$565K | 0.17% | 135 |
|
2023
Q3 | $5.32M | Buy |
78,581
+3,428
| +5% | +$232K | 0.19% | 122 |
|
2023
Q2 | $5.38M | Buy |
75,153
+791
| +1% | +$56.6K | 0.2% | 113 |
|
2023
Q1 | $5.16M | Sell |
74,362
-4,834
| -6% | -$336K | 0.21% | 121 |
|
2022
Q4 | $5.37M | Buy |
79,196
+11,358
| +17% | +$770K | 0.29% | 79 |
|
2022
Q3 | $3.72M | Sell |
67,838
-3,844
| -5% | -$211K | 0.25% | 101 |
|
2022
Q2 | $4.74M | Buy |
71,682
+8,263
| +13% | +$546K | 0.33% | 68 |
|
2022
Q1 | $4.21M | Buy |
63,419
+25,070
| +65% | +$1.66M | 0.29% | 83 |
|
2021
Q4 | $2.23M | Sell |
38,349
-579
| -1% | -$33.7K | 0.17% | 144 |
|
2021
Q3 | $2.34M | Buy |
38,928
+12,370
| +47% | +$743K | 0.24% | 106 |
|
2021
Q2 | $1.59M | Buy |
26,558
+6,113
| +30% | +$366K | 0.19% | 130 |
|
2021
Q1 | $1.02M | Buy |
20,445
+2,332
| +13% | +$116K | 0.18% | 150 |
|
2020
Q4 | $905K | Buy |
18,113
+3,555
| +24% | +$178K | 0.24% | 103 |
|
2020
Q3 | $798K | Buy |
14,558
+2,026
| +16% | +$111K | 0.31% | 86 |
|
2020
Q2 | $663K | Buy |
12,532
+2,443
| +24% | +$129K | 0.38% | 64 |
|
2020
Q1 | $451K | Buy |
10,089
+2,112
| +26% | +$94.4K | 0.38% | 83 |
|
2019
Q4 | $398K | Buy |
+7,977
| New | +$398K | 0.29% | 113 |
|